BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18483269)

  • 1. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2.
    Chen J; Deng F; Singh SV; Wang QJ
    Cancer Res; 2008 May; 68(10):3844-53. PubMed ID: 18483269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A protein kinase C/protein kinase D pathway protects LNCaP prostate cancer cells from phorbol ester-induced apoptosis by promoting ERK1/2 and NF-{kappa}B activities.
    Chen J; Giridhar KV; Zhang L; Xu S; Wang QJ
    Carcinogenesis; 2011 Aug; 32(8):1198-206. PubMed ID: 21665893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.
    Tanaka Y; Gavrielides MV; Mitsuuchi Y; Fujii T; Kazanietz MG
    J Biol Chem; 2003 Sep; 278(36):33753-62. PubMed ID: 12824193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.
    Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S
    Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase.
    Gesmundo I; Di Blasio L; Banfi D; Villanova T; Fanciulli A; Favaro E; Gamba G; Musuraca C; Rapa I; Volante M; Munegato S; Papotti M; Gontero P; Primo L; Ghigo E; Granata R
    Cancer Lett; 2019 May; 449():252-262. PubMed ID: 30790678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Kinase D3 (PKD3) Requires Hsp90 for Stability and Promotion of Prostate Cancer Cell Migration.
    Varga A; Nguyen MT; Pénzes K; Bátai B; Gyulavári P; Gurbi B; Murányi J; Csermely P; Csala M; Vántus T; Sőti C
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
    Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
    Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer.
    Johnson TR; Khandrika L; Kumar B; Venezia S; Koul S; Chandhoke R; Maroni P; Donohue R; Meacham RB; Koul HK
    Mol Cancer Res; 2008 Oct; 6(10):1639-48. PubMed ID: 18922979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PKD3 contributes to up-regulation of prostate-specific antigen in prostate cancer cells].
    Deng F; Wang CX; Xu WF; Feng L; Ke ZY; Wang QJ; Zou ZP
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1779-82. PubMed ID: 20813663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
    Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
    Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPA.
    Zou Z; Zeng F; Xu W; Wang C; Ke Z; Wang QJ; Deng F
    J Cell Sci; 2012 Oct; 125(Pt 20):4800-11. PubMed ID: 22797919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest.
    Sarfaraz S; Afaq F; Adhami VM; Malik A; Mukhtar H
    J Biol Chem; 2006 Dec; 281(51):39480-91. PubMed ID: 17068343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Kinase D2 and D3 Promote Prostate Cancer Cell Bone Metastasis by Positively Regulating Runx2 in a MEK/ERK1/2-Dependent Manner.
    Roy A; Prasad S; Chen Y; Chao Y; Liu Y; Zhao J; Wang QJ
    Am J Pathol; 2023 May; 193(5):624-637. PubMed ID: 36740185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15.
    Gervais M; Dugourd C; Muller L; Ardidie C; Canton B; Loviconi L; Corvol P; Chneiweiss H; Monnot C
    Mol Biol Cell; 2006 Sep; 17(9):3940-51. PubMed ID: 16822839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
    Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
    J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways.
    Li H; Wang X; Li N; Qiu J; Zhang Y; Cao X
    J Biol Chem; 2007 Feb; 282(7):4943-4950. PubMed ID: 17178731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
    Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
    Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.